Ursodeoxycholic Acid
Showing 1 - 25 of 8,001
Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection Trial in New Delhi (Ursodeoxycholic acid, Standard Medical
Not yet recruiting
- Liver Regeneration
- +2 more
- Ursodeoxycholic acid
- Standard Medical Treatment
-
New Delhi, IndiaInstitute of Liver and Biliary Sciences
Oct 18, 2023
Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Ursodeoxycholic acid (UDCA) 500 mg)
Recruiting
- Rheumatoid Arthritis
- Placebo
- Ursodeoxycholic acid (UDCA) 500 mg
-
Shibīn Al Kawm, EgyptMenoufia University Hospital
Aug 1, 2023
Gestational Diabetes Trial in Murcia (500 mg of ursodeoxycholic acid (UDCA), 500 mg of Placebo)
Completed
- Gestational Diabetes
- 500 mg of ursodeoxycholic acid (UDCA)
- 500 mg of Placebo
-
Murcia, SpainHospital Clínico Universitario Virgen de la Arrixaca
Nov 10, 2023
Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With
Recruiting
- Primary Biliary Cholangitis
- Placebo Combined With Ursodeoxycholic Acid
- Fenofibrate Combined With Ursodeoxycholic Acid
-
Xi'an, Shaanxi, ChinaYing han
Mar 3, 2023
COVID-19 Trial (Ursodeoxycholic acid)
Not yet recruiting
- COVID-19
- Ursodeoxycholic acid
- (no location specified)
Dec 20, 2022
Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)
Recruiting
- Cardiac Surgery
- Nirmatrelvir/ritonavir
- Ursodeoxycholic acid
-
Beijing, Beijing, ChinaFuwai Hospital
Jan 18, 2023
Diabetes, Type 2 Trial in Tanta, Shibin Al Kawm (Ursodeoxycholic acid)
Recruiting
- Diabetes Mellitus, Type 2
- Ursodeoxycholic acid
-
Tanta, El-Gharbia, Egypt
- +1 more
Jun 5, 2023
Ursodeoxycholic Acid on Preventing Covid-19 Infection in Organ
Completed
- Organ Transplantation
- COVID-19
- Medication history
- (no location specified)
Jan 12, 2023
Gestational Diabetes Trial in London (Metformin, Ursodeoxycholic Acid)
Recruiting
- Gestational Diabetes
- Metformin
- Ursodeoxycholic Acid
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Aug 17, 2022
Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)
Recruiting
- Primary Biliary Cholangitis
- Fenofibrate 200mg
- +2 more
-
Xi'an, Shaanxi, ChinaXijing Hospital
Mar 3, 2023
Diabetes, Type 2 Trial in Banja Luka (UDCA (Ursodeoxycholic acid), Placebo, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- UDCA (Ursodeoxycholic acid)
- +2 more
-
Banja Luka, Republic Of Srpska, Bosnia and HerzegovinaPublic Health Institution Dom zdravlja Banja Luka
Jun 8, 2022
Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)
Recruiting
- Primary Biliary Cholangitis
- Seladelpar 10 mg
- Placebo
-
Chandler, Arizona
- +3 more
Oct 2, 2023
Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg)
Recruiting
- Rheumatoid Arthritis
- Placebo
- +2 more
-
Shibīn Al Kawm, EgyptMenoufia University Hospital
Apr 5, 2022
Primary Biliary Cholangitis Trial in Beijing (ursodeoxycholic acid)
Recruiting
- Primary Biliary Cholangitis
- ursodeoxycholic acid
-
Beijing, ChinaPeking Union Medical College Hospital
Apr 28, 2022
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
Gastric Cancer Trial in Seoul (Patients who continued UDCA 300mg medication, Patients who discontinued UDCA 300mg prescription)
Recruiting
- Gastric Cancer
- Patients who continued UDCA 300mg medication
- Patients who discontinued UDCA 300mg prescription
-
Seoul, Korea, Republic ofDoJoong Park
Jun 6, 2022
Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of
Recruiting
- Hepatitis, Autoimmune
- +3 more
- Ursodeoxycholic acid combination of immunosuppressive agents
- Ursodeoxycholic Acid
-
Chengdu, Sichuan, ChinaWest China Hospital
Oct 26, 2021
COVID-19 Infection and Its Clinical Prognosis in Autoimmune
Recruiting
- COVID-19 Infection
- ursodeoxycholic acid
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Apr 11, 2023
Diabetes Trial in Xi'an (UDCA)
Recruiting
- Diabetes Mellitus
-
Xi'an, Shanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 11, 2022
Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)
Not yet recruiting
- Hepatitis D
- Ursodeoxycholic acid
- +2 more
-
Taipei, Taiwan
- +1 more
Jul 19, 2022
Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound
Not yet recruiting
- Biliary Atresia
- +2 more
- Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
- Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
- (no location specified)
Jun 28, 2023
sCD163 in PBC Patients - Assessment of Treatment Response
Recruiting
- Primary Biliary Cirrhosis
- +2 more
- Blood samples
- +3 more
-
Aarhus C, Region Midtjylland, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
Aug 11, 2022
Chinese Primary Biliary Cholangitis on Ursodeoxycholic Acid
Recruiting
- Primary Biliary Cholangitis (PBC)
- Ursodeoxycholic Acid
-
Beijing, ChinaCentre of non-infectious liver diseases, Beijing 302 Hospital, B
Aug 27, 2021
Polycystic Liver Disease, Polycystic Kidney, Autosomal Dominant Trial in Nijmegen, Amsterdam, San Sebastian (Ursodeoxycholic
Completed
- Polycystic Liver Disease
- Polycystic Kidney, Autosomal Dominant
- Ursodeoxycholic Acid
-
Nijmegen, Gelderland, Netherlands
- +2 more
Sep 16, 2021
Bone Regeneration Trial in Hyderabad (Ursodeoxycholic acid gel)
Recruiting
- Bone Regeneration
- Ursodeoxycholic acid gel
-
Hyderabad, Telangana, IndiaSVS Institute of Dental Sciences
Jun 17, 2021